Search results
Results From The WOW.Com Content Network
The degree of gluten cross contamination tolerated by people with non-celiac gluten sensitivity is not clear but there is some evidence that they can present with symptoms even after consumption of small amounts. [37] Sporadic accidental contaminations with gluten can reactivate movement disorders associated with non-celiac gluten sensitivity. [72]
Gluten-sensitive enteropathy–associated conditions are comorbidities or complications of gluten-related gastrointestinal distress (that is, gluten-sensitive enteropathy or GSE). GSE has key symptoms typically restricted to the bowel and associated tissues; however, there are a wide variety of associated conditions.
Refractory coeliac disease should not be confused with the persistence of symptoms despite gluten withdrawal [114] caused by transient conditions derived from the intestinal damage, [111] [112] [115] which generally revert or improve several months after starting a gluten-free diet, [116] [117] such as small intestinal bacterial overgrowth ...
The latest symptoms of COVID-19 are tied to new dominant subvariants – BQ.1 and BQ.1.1 – which now comprise the majority of cases reported in the U.S.
The most recent COVID-19 vaccine should offer protection against the XEC variant, Russo says. “The most recent version of the vaccine seems to be reasonably well-matched,” he says.
A 2022 U.K. study that gathered self-reported data on COVID-19 symptoms via smartphone apps indicated that a sore throat became a more prevalent sign when Omicron's dominance rose in 2021 ...
A recently proposed criterion to non-coeliac gluten sensitivity diagnosis concludes that an improvement of gastrointestinal symptoms and extra-intestinal manifestations higher than 50% with a gluten-free diet, assessed through a rating scale, may confirm the clinical diagnosis of non-coeliac gluten sensitivity. Nevertheless, this rating scale ...
Enteropathy-associated T-cell lymphoma (EATL), previously termed enteropathy-associated T-cell lymphoma, type I and at one time termed enteropathy-type T-cell lymphoma (ETTL), is a complication of coeliac disease in which a malignant T-cell lymphoma develops in areas of the small intestine affected by the disease's intense inflammation. [1]